ReWalk Robotics Stock (NASDAQ:LFWD)



Previous Close

$1.97

52W Range

$1.25 - $7.70

50D Avg

$1.74

200D Avg

$3.09

Market Cap

$23.23M

Avg Vol (3M)

$773.43K

Beta

2.06

Div Yield

-

LFWD Company Profile


ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

108

IPO Date

Sep 12, 2014

Website

LFWD Performance


Total Return %
1D
5D
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
LFWD
S&P 500
10.91%
-0.68%
33.23%
21.39%
-41.26%
-2.02%
-66.02%
-72.86%
-63.09%
-99.92%
-0.00%
1.75%
2.03%
4.09%
9.99%
4.29%
22.74%
39.50%
81.06%
190.18%

Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceSep 24Jun 24
Product$4.80M$5.13M

Fiscal year ends in Dec 23 | Currency in USD

LFWD Financial Summary


Dec 23Dec 22Dec 21
Revenue$13.85M$5.51M$5.97M
Operating Income$-23.61M$-19.10M$-12.65M
Net Income$-22.13M$-19.57M$-12.74M
EBITDA$-21.90M$-18.92M$-12.43M
Basic EPS$-0.37$-0.31$-0.27
Diluted EPS$-0.37$-0.31$-0.27

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q3 24Nov 12, 24 | 8:30 AM
Q2 24Aug 15, 24 | 8:30 AM
Q1 24May 15, 24 | 8:30 AM